aratinga.bio

📍 Villejuif, France🗓 Founded 2017👥 3 employees
Biotechnology Research🌐 aratinga.bio
Website LinkedIn
aratinga.bio is a preclinical stage company developing novel immunotherapies to treat cancer. To address unmet medical needs, aratinga.bio is developing its proprietary platform effective against both hematological cancers and solid tumors regardless of the type of previous treatments patients have experienced. The use of human T cells as therapeutics and the administration of anti-checkpoints are revolutionizing the way cancer is treated. We believe investments in research capabilities including access to state-of-the-art gene transfer and nucleotide-based technologies, will help accelerate the development of new and better options for immune-oncology therapeutics
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was aratinga.bio founded?
aratinga.bio was founded in 2017.
What industry is aratinga.bio in?
aratinga.bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is aratinga.bio based?
aratinga.bio is headquartered in Villejuif, France.